#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lip and/or oral cavity cancer Hodgkin's disease recurrent CDKL5 deficiency disorder Medullary thyroid cancer Acute myeloid leukaemia (in remission) Pleural mesothelioma Human papilloma virus immunisation Astrocytoma malignant Acute myeloid leukaemia Hypochondroplasia Hodgkin's disease refractory Endocrine ophthalmopathy Hereditary angioedema Haemophagocytic lymphohistiocytosis Haemophilia B with anti factor IX More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Trials in Disease Atypical haemolytic uraemic syndrome – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Paraneoplastic neurological syndrome – Trials in Disease Bronchopulmonary dysplasia – Treatment Progressive multifocal leukoencephalopathy – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Breast angiosarcoma – Diagnostics Systemic mastocytosis Mucopolysaccharidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aaa802 Caspofungin Acetate Atezolizumab Nirogacestat Hydrobromide Ly3298176 Abc-15Bo-116 Cannabis Sativa Flower ANTI-GD2-800CW Bempikibart Vincristine Sulfate Andexanet Alfa Tucatinib 10-1074-Ls Syn2 Zinc Acexamate Nemolizumab Azetukalner Bintrafusp Alfa Betamethasone Valerate Lbl-007 More therapies…

    Learn about Your Condition

    Athetosis Insomnia Autoimmune haemolytic anaemia Thalassaemia beta Deafness traumatic Hypochondroplasia Testis cancer Pleural mesothelioma Cardiomyopathy Endometrial cancer stage IV Metastatic gastric cancer Neuralgia Hyperthyroidism Femur fracture Erdheim-Chester disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Inhaled Colistimethate Sodium for Adults with Bronchiectasis and New Asymptomatic Pseudomonas Aeruginosa Infection

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Colistimethate Sodium
    Germany

  • Study on Stopping Dasatinib in Patients with Chronic Myeloid Leukemia After a Previous Attempt to Stop Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Dasatinib
    Denmark France The Netherlands

  • Study on the Effects of Finerenone and SGLT2 Inhibitors on Heart and Kidney Health in Patients with Type 2 Diabetes and Chronic Kidney Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Denmark

  • Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Loperamide Hydrochloride
    • Navtemadlin
    • Ondansetron
    Austria Belgium Croatia Czechia France Germany +7

  • Study on Baricitinib for Patients with Calcium Pyrophosphate Deposition Disease (CPPD) Using Methotrexate Sodium and Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Tiemonium Methylsulphate
    • Hydroxychloroquine Sulfate
    • Colchicine
    Italy

  • Study on Tranexamic Acid to Prevent Blood Loss in Women with Placenta Previa Undergoing Cesarean Delivery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Placenta praevia
    • Postpartum haemorrhage
    Investigated Drugs:
    • Tranexamic Acid
    France
Previous Page
1 … 371 372 373 374 375 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!